Condor Capital Management Portfolio holdings
Top Buys
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
OASI
O'Shares FTSE Asia Pacific Quality Dividend ETF
OASI
|
+$2.75M |
| 2 |
AGN
Allergan plc
AGN
|
+$1.46M |
| 3 |
Vanguard FTSE Europe ETF
VGK
|
+$1.25M |
| 4 |
ScottsMiracle-Gro
SMG
|
+$701K |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$513K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 9.55% |
| 2 | Financials | 4.78% |
| 3 | Industrials | 4.27% |
| 4 | Technology | 4.23% |
| 5 | Consumer Discretionary | 3.85% |
Similar funds
Condor Capital Management's Q4 2018 Portfolio in Review
As of Q4 2018, Condor Capital Management held 190 positions worth $548M, down 0.02% from $548M the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Condor Capital Management deployed $80.1M of net new capital in Q4 2018, opening 24 new positions and adding to 78 existing holdings. Its largest new stake was Vanguard Short-Term Corporate Bond ETF: 240,185 shares worth $18.7M.
By sector, the portfolio is most concentrated in Healthcare at 9.5% of assets, down from 11% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Vanguard FTSE Europe ETF, an estimated $1.25M trimmed.
- Condor Capital Management's largest Q4 2018 buy was Vanguard Short-Term Corporate Bond ETF: 240,185 shares worth $18.7M.
- Condor Capital Management added most to Amazon in Q4 2018, an estimated $2.07M increase.
- Condor Capital Management's biggest Q4 2018 reduction was Vanguard FTSE Europe ETF, cutting an estimated $1.25M.
- Condor Capital Management fully exited O'Shares FTSE Asia Pacific Quality Dividend ETF in Q4 2018, selling an estimated $2.75M.
- Condor Capital Management's ten largest holdings make up 33% of its $548M portfolio in Q4 2018.
- Condor Capital Management opened 24 new positions and closed 7 in Q4 2018.
- Condor Capital Management's portfolio value fell 0.02% quarter-over-quarter to $548M.
Based on Condor Capital Management's 13F filing for Q4 2018, filed 8 Feb 2019.